Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study
Oliver A. Cornely(University of Cologne), Sílvia Gómez-Zorrilla(Hospital Universitario Virgen del Rocío), Angela Cano Yuste, Karen Cheng, José Miguel Cisneros(Hospital Universitario Virgen del Rocío), Julia Guzmán-Puche(Instituto Maimónides de Investigación Biomédica de Córdoba), Boudewijn de Jonge, Juan Pablo Horcajada(Evidence (Italy)), Silvia Jiménez‐Jorge(Instituto de Salud Carlos III), Enrique Montero-Mateos, Clara Rosso-Fernández(Instituto de Biomedicina de Sevilla), Rafael Morales-Soriano, Pilar Retamar, José Antonio López-Ruiz(Hospital Universitario Virgen del Rocío), Julián Torre‐Cisneros(Instituto de Salud Carlos III), Esther Calbo(Universitat Internacional de Catalunya), D. Postil(Hôpital Dupuytren), Cristina Roca-Oporto, Guy Turner(Pfizer (United States)), Jan Rupp(University of Lübeck), Marc Bludau, Ulrike Zettelmeyer(University of Cologne), Susan Raber(Pfizer (United States)), Michele Wible, Javier Padillo–Ruiz, Seamus O’Brien(Pfizer (United States)), Luis Tallón‐Aguilar(Hospital Universitario Virgen Macarena), Alison Luckey(Global Antibiotic Research & Development Partnership), María Jesús Rodríguez-Hernández(Hospital Universitario Virgen del Rocío), Guillaume Piessen(Centre National de la Recherche Scientifique), M. Montejo Baranda, Dorothee Arenz(University of Cologne), Virginia Palomo Jiménez(Hospital Universitario Virgen del Rocío), Lucía Boix-Palop, Ana Cristina Padial Aguado, Christian Queckenberg(University of Cologne), R. M. Jiménez Rodríguez(Hospital Universitario Virgen del Rocío), Carlos García Bernedo
Cited by 123
Related Papers
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|2004|921
Anidulafungin versus Fluconazole for Invasive Candidiasis
|New England Journal of Medicine|2007|896